ArticleBioMed research international2014

The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.

Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.